ORIGINAL RESEARCH
Published on 30 Sep 2025
Breaking the heterogeneity barrier: a robust prognostic signature for survival stratification and immune profiling in triple-negative breast cancer
doi 10.3389/fimmu.2025.1611917
- 491 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III
Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III
10k
Total downloads
50k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 29 Sep 2025
Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma
doi 10.3389/fimmu.2025.1663943
- 106 views
ORIGINAL RESEARCH
Published on 24 Sep 2025
Effective dose to immune cells combined with platelet-to-lymphocyte ratio predicts lymphopenia and prognosis in unresectable locally advanced non-small cell lung cancer
doi 10.3389/fimmu.2025.1657972
- 509 views
ORIGINAL RESEARCH
Published on 18 Sep 2025
TGM2 regulated by transcription factor NR3C1 drives p38 MAPK-mediated tumor progression and immune evasion in lung squamous cell carcinoma
doi 10.3389/fimmu.2025.1595907
- 568 views
CASE REPORT
Published on 14 Aug 2025
Lysine methyltransferase 2D deficiency drives complete response to pembrolizumab in PD-L1-High cholangiocarcinoma: a case report and review of literature
doi 10.3389/fimmu.2025.1616361
- 1,330 views
ORIGINAL RESEARCH
Published on 30 Jul 2025
Comprehensive analysis of regulatory B Cell related genes in prognosis and therapeutic response in lung adenocarcinoma
doi 10.3389/fimmu.2025.1595408
- 1,807 views
- 1 citation
ORIGINAL RESEARCH
Published on 09 Jul 2025
CPLX1 is a novel prognostic biomarker in CRC correlating with immunotherapy resistance and ferroptosis
doi 10.3389/fimmu.2025.1589423
- 1,464 views
ORIGINAL RESEARCH
Published on 30 May 2025
GPR65 is a novel immune biomarker and regulates the immune microenvironment in lung adenocarcinoma
doi 10.3389/fimmu.2025.1572757
- 2,621 views
ORIGINAL RESEARCH
Published on 30 May 2025
Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment
doi 10.3389/fimmu.2025.1553882
- 1,791 views
SYSTEMATIC REVIEW
Published on 26 May 2025
Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1592761
- 1,609 views
- 2 citations
SYSTEMATIC REVIEW
Published on 16 May 2025
Prognostic value of the systemic immune-inflammation index in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fonc.2025.1532343
- 1,545 views
REVIEW
Published on 08 May 2025
Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer
doi 10.3389/fimmu.2025.1554871
- 3,537 views
- 2 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: